Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025The FASEB JournalOpen Access

Gut Microbiota‐Derived Metabolites Orchestrate Metabolic Reprogramming in Diabetic Cardiomyopathy: Mechanisms and Therapeutic Frontiers

View Full Paper
Ask AI
Bookmark
Share

Authors

JJJingyu JinXYXinyu YangRFRu Feng

Discussion

Loading...

Member takes

Overview

Literature review highlights gut microbiota's role in metabolic reprogramming in diabetic cardiomyopathy, suggesting innovative therapies.

Key Points

  • Gut microbiota-derived metabolites influence metabolic pathways related to diabetic cardiomyopathy.
  • Short-chain fatty acids and other metabolites impact insulin resistance and cardiac fibrosis in diabetic models.
  • Therapeutic interventions like probiotics and drugs are promising for restoring cardiac function in diabetes.
  • Further research is needed to translate animal findings into effective human therapies for diabetic heart disease.

Cite This Study

Jin et al. (2025) studied this question.

synapsesocial.com/papers/68c23b4ab210217d64783aa9https://doi.org/10.1096/fj.202501579rr
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of gut microbiota and its metabolites in diabetic cardiomyopathy: from pathogenesis to interventions2025
  2. 2Mitochondrial metabolic reprogramming in diabetic cardiomyopathy2026 · 1 citations
  3. 3Diabetic cardiomyopathy: Target immune cell from mechanism to treatment2026
  4. 4MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy2025
  5. 5Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy2025 · 9 citations